Adam Scott Levy's Net Worth
$4.17 Million
Who is Adam Scott Levy?
Adam Scott Levy has an estimated net worth of $4.17 Million. This is based on reported shares across multiple companies, which include Mineralys Therapeutics, Inc., MIRAGEN THERAPEUTICS, INC., and Brickell Biotech, Inc..
SEC CIK
Adam Scott Levy's CIK is 0001693134
Past Insider Trading and Trends
2023 was Adam Scott Levy's most active year for acquiring shares with 3 total transactions. Adam Scott Levy's most active month to acquire stocks was the month of January. 2024 was Adam Scott Levy's most active year for disposing of shares, totalling 2 transactions. Adam Scott Levy's most active month to dispose stocks was the month of May. 2023 saw Adam Scott Levy paying a total of $100,000.00 for 123,768 shares, this is the most they've acquired in one year. In 2024 Adam Scott Levy cashed out on 107,572 shares for a total of $1,394,112.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mineralys Therapeutics, Inc. (MLYS) Snapshot price: $11.23
CFO and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.34% | -10.76K |
$13.57 | -$146,003.69 | 236.85K |
Scheduled
|
Oct 11
| ||
Form 4
| -4.16% | -10.76K |
$13.14 | -$141,394.31 | 247.61K |
Scheduled
|
Jul 11
| ||
Form 4
| -27.48% | -96.81K |
$12.94 | -$1,252,718.33 | 255.46K |
Scheduled
|
Jun 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| +1.81% | 6.25K |
$16.00 | $100,000.00 | 350.81K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MIRAGEN THERAPEUTICS, INC. (VRDN) Snapshot price: $14.09
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +626.90% | 9.09K |
$5.50 | $49,995.00 | 10.54K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 200 |
$7.55 | $1,510.00 | 200 |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Brickell Biotech, Inc. (FRTX) Snapshot price: $0.95
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||